Testing effectiveness (Phase 2)Ended earlyNCT00053508
What this trial is testing
Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
Who this might be right for
Smallpox
Sanofi Pasteur, a Sanofi Company 274